Articles
| Open Access |
DOI: Diagnosis And Treatment Of Emphysematous Pyelonephritis In Patients With Diabetes
Nurillo Makhmudov , Docent, Department Of Internal Medicine, Fergana Medicine Institute, Uzbekistan Zukhra Kosimova , Assistant Docent, Department Of Internal Medicine, Fergana Medicine Institute, UzbekistanAbstract
In this study we report on our experience in treating two patients diagnosed with a rare disease of emphysematous pyelonephritis, who were admitted to the Urology department of Fergana Medical Institute during 2018. We provide details on each test conducted on patients, pre- and post-surgery. Our analysis shows that to prevent complications in patients with diabetes mellitus, dispensary observation with control of glucose levels, urine and blood tests is necessary.
Keywords
Emphysematous Pyelonephritis, Diabetes
References
Kukhtevich A.V. Gordovskaya N.B. Acute pyelonephritis // BC. Mother and child. - 2018. — No. 23. - P. 5.
Lopatkin N.A., Pugachev A.G., Apolikhin O.I. Urology. - M .: Medicine, 2002 .-- 348 p.
International classification of diseases from 2010 // ICD-10 Version: 2010. [Electronic resource].
Russian clinical guidelines. Urology // Russian Association of Urologists. - M., 2016 .-- S. 429.
Chung V.Y., Tai C.K., Fan C.W., Tang C.N. Severe acute pyelonephritis: a review of clinical outcome and risk factors for mortality // Hong. Kong. Med. J. - 2014. - Vol. 20, No. 4. - P. 285-9.
FDA updates warnings for fluoroquinolone antibiotics // FDA News Release. [Electronic resource].
Lu Y.C., Chiang B.J., Pong Y.H., et al. Emphysematous pyelonephritis: clinical characteristics and prognostic factors // Int. J. Urol. - 2014. - Vol. 21, No. 3. - P. 277-82.
Mc Lellan L.K., Hunstad D.A. Urinary Tract Infection: Pathogenesis and Outlook // Trends. Mol. Med. - 2016. - Vol. 22, No. 11. - P. 946-57.
Article Statistics
Copyright License
Copyright (c) 2021 The American Journal of Medical Sciences and Pharmaceutical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.